Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies
====================================================================================================================================================

* Gabrielle Leclercq
* Hélène Haegel
* Anneliese Schneider
* Anna Maria Giusti
* Estelle Marrer-Berger
* Christophe Boetsch
* Antje-Christine Walz
* Vesna Pulko
* Johannes Sam
* John Challier
* Cristiano Ferlini
* Alex Odermatt
* Pablo Umaña
* Marina Bacac
* Christian Klein